In this episode, we’re joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women’s health research and what she hopes to achieve as a founding member of the Milken Institute’s Women’s Health Network. The post MedCity FemFwd: How Evvy Is Advancing Women’s Health…
How can AI determine who gets matched to new therapies, who is identified for clinical trials, and how patient tracking is scaled across large populations? Chip is joined by Dr. A.J. Blood, a practicing cardiologist at Brigham and Women’s Hospital and the co-founder and Chief Executive Officer of AIwithCare, a startup company that delivers AI-enabled…
A new National Academies committee study report, A New Vision for Women’s Health Research: Transformative Change at the National Institutes of Health, was co-chaired by Alina Salganicoff, senior vice president and director of women’s health policy. The report finds that while the National Institutes of Health (NIH) has made important contributions that have led to…More
Chamber’s Series A round was led by Frist Cressey Ventures, with participation from General Catalyst, AlleyCorp, American Family Ventures, Company Ventures, Optum Ventures, Healthworx Ventures and Black Opal Ventures. The post Chamber Secures $60M to Advance Value-Based Cardiology appeared first on MedCity News.
Protagonist Therapeutics’ drug rusfertide reduced the need for phlebotomies as a way to treat the rare blood cancer polycythemia vera. Longer-term Phase 3 data for the Takeda Pharmaceutical-partnered peptide drug were presented during the annual meeting of the American Society of Hematology. The post Shining Light on How Protagonist, Takeda Drug Brings Treatment of a…
CHICO, Calif. — Olivia Owlett chose to do her primary care residency in this Northern California college town largely because it faces many of the same health care challenges she grew up with. Owlett is one of four residents in the inaugural class of a three-year family medicine residency program run by the local nonprofit…
Bristol Myers Squibb’s partnership with BioNTech makes it the third big pharma company to strike a deal to gain access to a PD-L1/PD-1 and VEGF bispecific antibody with potential use in drug combinations to treat cancer. The deal calls for the two companies to share in the development of BioNTech’s drug and co-commercialize the asset…
Once data starts moving across multiple systems, it becomes hard to track unless you’ve been very intentional about it from the start. The post Where Healthcare Data Systems Fail and How to Build Them Better appeared first on MedCity News.
HELENA, Mont. — In 2023, a group of 16 young Montanans won a much-heralded climate change case that said the state had deprived them of a “clean and healthful environment,” a right enshrined in Montana’s constitution. Their victory in Held v. Montana, later upheld by the state Supreme Court, resounded across the country, showing that…
OAK FLAT, Ariz. — Carrying eagle feathers and chanting prayers, Western Apache runners hit the road on a roughly 80-mile journey this month to try to save their sacred land from being fast-tracked by President Donald Trump into a copper mine. This nationally watched battle, which hinges on religious freedom, awaits the U.S. Supreme Court….